Levothyroxine Sodium Injection, Solution
Product Images NDC 63323-885

8 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 63323-885). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Lev19 0002 01)

Structural Formula (Lev19 0002 01)
Chemical structure of Levothyroxine Sodium, showing its molecular components including aromatic rings, hydroxyl groups, and the sodium salt of the amino acid moiety.*
FDA Label Image

Fresenius Logo (Lev19 0002 02)

FDA Label Image

Levot-label-01.jpg (Levot Label 01)

Levot-label-01.jpg (Levot Label 01)
Label for Levothyroxine Sodium Injection by Fresenius Kabi USA, LLC, containing 100 mcg per 5 mL (20 mcg per mL) solution for intravenous use. The vial is 5 mL single-dose, preservative free, with a note to discard unused portion. Storage instructions and barcode are also shown.*
FDA Label Image

Levot-label-02.jpg (Levot Label 02)

Levot-label-02.jpg (Levot Label 02)
Packaging label for Levothyroxine Sodium Injection 100 mcg per 5 mL (20 mcg per mL) by Fresenius Kabi USA, LLC. The label indicates a 5 mL single-dose vial for intravenous use, preservative-free, with storage instructions from 20° to 25°C (68° to 77°F). It includes manufacturer information and barcode details.*
FDA Label Image

Levot-label-03.jpg (Levot Label 03)

Levot-label-03.jpg (Levot Label 03)
Label for Levothyroxine Sodium Injection, 100 mcg/mL (500 mcg per 5 mL) in a 5 mL single-dose vial. The product is preservative free and intended for intravenous use. Manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL. The label includes storage information and a barcode.*
FDA Label Image

Levot-label-04.jpg (Levot Label 04)

Levot-label-04.jpg (Levot Label 04)
Label for Levothyroxine Sodium Injection 500 mcg per 5 mL (100 mcg per mL) single-dose vial by Fresenius Kabi USA, LLC. The label includes product name, strength, dosage form, NDC 63323-895-10, and directions for intravenous use. It states the product is preservative-free and contains a 5 mL vial with instructions to discard unused portions. Storage instructions (20° to 25°C) and ingredient details are also included.*
FDA Label Image

Levot-label-05.jpg (Levot Label 05)

Levot-label-05.jpg (Levot Label 05)
Levothyroxine Sodium Injection label showing 40 mcg per mL concentration, totaling 200 mcg per 5 mL vial. The label indicates it is preservative-free, sterile, for intravenous use, and is a single-dose vial. It includes storage instructions and manufacturer Fresenius Kabi USA, LLC, Lake Zurich, IL.*
FDA Label Image

Levot-label-06.jpg (Levot Label 06)

Levot-label-06.jpg (Levot Label 06)
Packaging label for Levothyroxine Sodium Injection, 200 mcg per 5 mL (40 mcg per mL) solution by Fresenius Kabi USA, LLC. The label indicates a 5 mL single-dose vial for intravenous use, preservative-free, with directions to discard any unused portion. Storage instructions specify 20° to 25°C (68° to 77°F), and the container closure is not made with natural rubber latex.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.